Prelude Capital Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-18,227
| Closed | -$116K | – | 1284 |
|
|
2024
Q2 | $116K | Sell |
18,227
-54,608
| -75% | -$349K | 0.01% | 991 |
|
|
2024
Q1 | $548K | Buy |
72,835
+47,946
| +193% | +$361K | 0.03% | 535 |
|
|
2023
Q4 | $230K | Buy |
+24,889
| New | +$230K | 0.02% | 753 |
|
|
2022
Q3 | – | Sell |
-16,581
| Closed | -$240K | – | 1590 |
|
|
2022
Q2 | $240K | Buy |
+16,581
| New | +$240K | 0.01% | 1016 |
|
|
2020
Q1 | – | Sell |
-300
| Closed | -$10K | – | 1184 |
|
|
2019
Q4 | $10K | Buy |
+300
| New | +$10K | ﹤0.01% | 1237 |
|